title: A non-fatal pneumonia due to Legionella longbeachae in a patient with systemic lupus erythematosus.
authors.affiliation: 1 Department of Clinical Immunology, Strasbourg University Hospital, Strasbourg, France.
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.affiliation: 1 Department of Clinical Immunology, Strasbourg University Hospital, Strasbourg, France.
authors.forename: N
authors.initials: N
authors.lastname: Keller
authors.affiliation: 2 Department of Bacteriology, Strasbourg University Hospital, Strasbourg, France.
authors.forename: A
authors.initials: A
authors.lastname: Martin
authors.affiliation: 2 Department of Bacteriology, Strasbourg University Hospital, Strasbourg, France.
authors.forename: E
authors.initials: E
authors.lastname: Twizeyimana
authors.affiliation: 3 Department of Infectious and Tropical Diseases, Strasbourg University Hospital, Strasbourg, France.
authors.forename: X
authors.initials: X
authors.lastname: Argemi
authors.affiliation: 3 Department of Infectious and Tropical Diseases, Strasbourg University Hospital, Strasbourg, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Hansmann
authors.affiliation: 1 Department of Clinical Immunology, Strasbourg University Hospital, Strasbourg, France.
authors.forename: T
authors.initials: T
authors.lastname: Martin
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D044128:Legionella longbeachae / Q000302:isolation & purification*; D007876:Legionellosis / Q000175:diagnosis* / Q000188:drug therapy; D064704:Levofloxacin / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D011014:Pneumonia / Q000188:drug therapy / Q000382:microbiology*; D015572:Spiramycin / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D064704:Levofloxacin; D015572:Spiramycin